Pharmaceutical Technology4 天
Acetylcysteine zidrimer by Orpheris for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Acetylcysteine zidrimer is under clinical development by Orpheris and currently in Phase II for Amyotrophic Lateral Sclerosis.
Pharmaceutical Technology4 天
Acetylcysteine zidrimer by Orpheris for Alzheimer’s Disease: Likelihood of Approval
Acetylcysteine zidrimer is under clinical development by Orpheris and currently in Phase II for Alzheimer's Disease.